Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report) hit a new 52-week high during trading on Thursday . The stock traded as high as $16.45 and last traded at $15.40, with a volume of 1005437 shares trading hands. The stock had previously closed at $16.05.
Silverback Therapeutics Price Performance
The firm has a 50-day moving average of $13.65 and a 200 day moving average of $10.87. The stock has a market capitalization of $555.29 million, a price-to-earnings ratio of -6.63 and a beta of 0.60.
Silverback Therapeutics Company Profile
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Featured Articles
- Five stocks we like better than Silverback Therapeutics
- Financial Services Stocks Investing
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- How Investors Can Find the Best Cheap Dividend Stocks
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- What Are Growth Stocks and Investing in Them
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.